J. Scott Wolchko
2015
In 2015, J. Scott Wolchko earned a total compensation of $1.1M as President, Chief Executive Officer and Director at Fate Therapeutics, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $54,944 |
|---|---|
| Option Awards | $238,714 |
| Salary | $351,795 |
| Stock Awards | $451,344 |
| Total | $1,096,797 |
Wolchko received $451.3K in stock awards, accounting for 41% of the total pay in 2015.
Wolchko also received $54.9K in non-equity incentive plan, $238.7K in option awards and $351.8K in salary.
Rankings
In 2015, J. Scott Wolchko's compensation ranked 7,508th out of 13,638 executives tracked by ExecPay. In other words, Wolchko earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,508 out of 13,638 | 45th |
Division Manufacturing | 2,834 out of 5,187 | 45th |
Major group Chemicals And Allied Products | 1,026 out of 1,857 | 45th |
Industry group Drugs | 827 out of 1,531 | 46th |
Industry Biological Products, Except Diagnostic Substances | 143 out of 260 | 45th |
Source: SEC filing on March 22, 2017.
Wolchko's colleagues
We found three more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2015.